NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET Ā | Source: NKGen Biotech, Inc. SANTA ANA,…
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
July 09, 2025 16:16 ET Ā | Source: Rhythm Pharmaceuticals, Inc. BOSTON, July…
Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
The Dermatology Group of Arkansas Welcomes Double Board-Certified Dermatologist to Practice
LITTLE ROCK, Ark., July 04, 2025 (GLOBE NEWSWIRE) -- The Dermatology Group…
MEI Micro partners with Steadman Philippon Research Institute in new technology development
SANTA BARBARA, Calif., June 26, 2025 /PRNewswire/ -- MEI Micro, Inc. is…
‘Haven of Hope’ – Shelter Home for Underprivileged Cancer Patients Inaugurated in Kochi
The 'Haven of Hope' building, built under South Indian Bank's CSR initiative…
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team
Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to…
ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe
LEATHERHEAD, England, July 3, 2025 /PRNewswire/ -- MatOrthoĀ® is proud to announce…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes AssociationāsĀ® 85th Scientific Sessions, showed…
GE HealthCare drives innovation in theranostics with latest technological advances
GE HealthCare is helping advance clinical and operational excellence in theranostics and…
